Advances in Animal Models and Precision Medicine for Cancer Research

Dear Colleagues,

Treating individual patients based on specific factors, such as biomarkers, is what differentiates precision medicine from standard treatment regimens. Although precision medicine can be applied to almost any branch of medicine, it is perhaps most easily applied to the field of oncology. The arrival of precision medicine has transformed translational cancer research, suggesting an approach that is patient-focused, with treatment choices directed by prognostic/predictive/monitoring biomarkers. The overall aim of translational research is to produce meaningful results that can quickly benefit cancer patients. Humans are complex organisms; if translational research is to be carried out, the models used should mimic that complexity.

Animal models have been vital to cancer research, having been used in studies ranging from the investigation of the mechanisms of cancer development/progression, to studies on cancer drug screening and biomarker research. Major advancements have been made in recent decades on animal cancer models, which have become progressively more complex due to the use of new and improved technologies.

In this Special Issue, we invite authors to submit articles focusing on animal models and how their use can lead to advancements in precision medicine for cancer.

Dr. James Meehan
Dr. Mark E. Gray
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• animal models
• cancer
• precision medicine